Skip to content

Abstract 15431: The Association Between Peak High-Sensitivity Troponin-T Concentration and Risk of Heart Failure in Patients with Myocardial Infarction, Unstable Angina, and Suspected Myocardial Infarction

Nov 2026 · Circulation · 0 citations

Abstract

Background: In patients presenting with suspected acute coronary syndrome (ACS), peak high-sensitivity troponin-T (hsTnT) has been associated with an increased risk of heart failure; however, whether hsTnT is independently associated with subsequent heart failure regardless of the final diagnosis is currently unknown. Purpose: To examine the short- and long-term associations between peak hsTnT and subsequent hospitalization or outpatient contact for heart failure in subjects with suspected ACS stratified by final diagnosis, i.e., myocardial infarction, unstable angina, or suspected myocardial infarction. Methods/Approach: We used Danish nationwide registry data from 2012 through 2019 to identify individuals with no prior history of heart failure who had two hsTnT measurements (99th percentile: 13.5 ng/l) taken at presentation, 1-7 hours apart, during hospitalization for suspected ACS. First, we stratified the population according to the final diagnosis made during hospitalization (i.e., myocardial infarction, unstable angina, or suspected myocardial infarction). We then grouped individuals per peak quartiles (Q1-Q4) based on the first two hsTnT measurements (Q1: <=9 ng/l, Q2: 10-19 ng/l, Q3: 20-263 ng/l, Q4: >=264 ng/l). Finally, we calculated the standardized absolute risk of hospitalization or outpatient contact for heart failure at 0-30 days and 31-365 days within each hsTnT peak quartile category, using multivariable Cox regression with average treatment effect modeling. Results: We included 26,835 individuals; 38.8% received a diagnosis of myocardial infarction, 5.1% unstable angina, and 56.1% suspected myocardial infarction. The median age was 64.2 years, 59.5% were male, 18.1% had coronary artery disease, and 7.2% had undergone prior revascularization. A total of 1,122 individuals were diagnosed with heart failure within the first 30 days, and 707 individuals were diagnosed between days 31-365. The absolute risk of heart failure was positively associated with peak hsTnT concentrations in each group, at both 0-30 days and 31-365 days. The final diagnosis modified the prognostic implications of peak hsTnT (P-interaction=0.03), but a relative gradient across the peak hsTnT quartiles remained. Individuals with suspected myocardial infarction in the Q4 group had a very high standardized absolute risk of incident heart failure (0-30 days: 14.28%, 95% confidence interval [CI]: 10.66 to 17.91; 31-365 days: 8.53%, 95% CI: 5.24 to 11.82). The results are shown in Table 1. Conclusions: In individuals presenting with suspected ACS, higher peak hsTnT concentrations were associated with higher risks of subsequent heart failure within both 0-30 days and 31-365 days. This risk gradient was observed irrespectively of whether individuals were discharged with a final diagnosis of myocardial infarction, unstable angina, or suspected myocardial infarction.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.